Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b [7]

American Journal of Gastroenterology

Volumn 97, Issue 3, 2002, Pages 766-767

  Iwasa, Motoh ^a   Kaito, Masahiko ^b   Ikoma, Jiro ^b   Takeo, Masaki ^b   Imoto, Ichiro ^b   Adachi, Yukihiko ^b   Yamauchi, Koji ^b   Koizumi, Reiko ^b   Teraguchi, Susumu ^b  

^a MIE UNIVERSITY   (Japan)

^b MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; INTERFERON; LACTOFERRIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; CANCER PREVENTION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIET SUPPLEMENTATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; RNA ANALYSIS; SIDE EFFECT; VIREMIA; VIRUS LOAD; VIRUS TYPING;

EID: 0036127867     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)04135-1     Document Type: Letter

References (3)

1. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: Univariate and multivariate analysis
2. Hepatitis C virus envelope proteins bind lactoferrin
3. Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: A pilot study